Analysis of a publicly available microarray dataset showed that cyclin A2 was the only member of the cyclin family that was significantly downregulated upon GATA3 overexpression in MDA-MB-231 breast cancer cells [32] (see Additional file 1: Figure S12). This evidence concerns the gene CCNA2 and breast cancer.